CTMX
CTMX

Cytomx Therapeutics Inc

NASDAQ · Biotechnology
$5.67
+0.43 (+8.21%)
Analyst Consensus
Strong Buy
14 analysts
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +1,011.8% upside
Low Target $39.26
Average Target $63.04
High Target $88.15
Current Price $5.67
Current
$5.67
Target
$63.04
$39.26 $63.04 avg $88.15